Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6170563 | 0.73 | KDM4E (0.39) | PTPN1GSK3BMAPT | |
| SCHEMBL21181779 | 0.71 | HRH4 (0.34) | MAPTHRH4 | |
| SCHEMBL27554810 | 0.70 | GSK3B (0.38) | PTPN1GSK3BMAPT | |
| Bromide SCHEMBL6169293 | 0.69 | GSK3B (0.37) | PTPN1GSK3BMAPT | |
| SCHEMBL18374711 | 0.67 | PRKCI (0.34) | PPARGPPARA | |
| SCHEMBL29365642 | 0.67 | CTNNB1 (0.51) | PTPN1GSK3BMAPT | |
| SCHEMBL4366167 | 0.67 | CTNNB1 (0.51) | PTPN1GSK3BMAPT | |
| SCHEMBL6110659 | 0.66 | KDM4E (0.46) | PTPN1GSK3BMAPT | |
| Bromide SCHEMBL4353378 | 0.66 | CTNNB1 (0.50) | PTPN1GSK3BMAPT | |
| SCHEMBL6170342 | 0.64 | GSK3B (0.41) | PTPN1GSK3BMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020198466-A9 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | CURASEN THERAPEUTICS, INC. (US) | 2020-12-30 | — | — | WO | disclosed |
| WO-2020198466-A1 | BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME | CURASEN THERAPEUTICS, INC. (US) | 2020-10-01 | — | — | WO | disclosed |